Recent Advances in Boron Delivery Agents for Boron Neutron Capture Therapy (BNCT)
Authors:
- 24 April 2018
- book chapter
- Published by Wiley
- p. 298-342
Abstract
No abstract availableKeywords
This publication has 154 references indexed in Scilit:
- Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1European Journal of Medicinal Chemistry, 2013
- Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head-and-Neck Cancer: Final Analysis of a Phase I/II TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapyApplied Radiation and Isotopes, 2011
- l-Boronophenylalanine-Mediated Boron Neutron Capture Therapy for Malignant Glioma Progressing After External Beam Radiation Therapy: A Phase I StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Incorporation of Cesium Borocaptate onto Silicon Nanowires as a Delivery Vehicle for Boron Neutron Capture TherapyChemistry of Materials, 2009
- Biological evaluation of boronated unnatural amino acids as new boron carriersApplied Radiation and Isotopes, 2009
- Novel types of boronated chlorin e6 conjugates via ‘click chemistry’Applied Organometallic Chemistry, 2009
- Agonist induced receptor internalization of neuropeptide Y receptor subtypes depends on third intracellular loop and C-terminusCellular Signalling, 2008
- Synthesis, Aggregation and Cellular Investigations of Porphyrin–Cobaltacarborane ConjugatesChemistry – A European Journal, 2007
- Biodistribution of Boron Compounds in an Animal Model of Human Undifferentiated Thyroid Cancer for Boron Neutron Capture TherapyMolecular Pharmaceutics, 2005